TagsOncology 
Thriving Beyond the Challenges of Multiple Myeloma Post- Transplantation

Multiple myeloma (MM) is a clonal plasma cell disorder characterised by excess production of monoclonal immunoglobulins and light chains that can ultimately lead to specific end-organ damage 1 . Notably, MM is the second most common haematologic mal...

Oct 22, 2024
The Unmet Needs in Relapse/ Refractory Multiple Myeloma: A Clinical Challenge

Multiple myeloma (MM) is a haematologic malignancy characterised by abnormal clonal plasma cells in the bone marrow with a potential for uncontrolled growth causing destruction, osseous lesion, acute kidney injury (AKI), anaemia, and hypercalcaemia....

Aug 20, 2024
The Ever-Changing Landscape of Unresectable Hepatocellular Carcinoma

Paradigm Shift in Management of Unresectable Hepatocellular Carcinoma (uHCC) In Hong Kong, liver cancer is the fifth most common cancer (with 1,771 new cases of liver cancer reported in 2021) and the third most common cause of cancer-related deaths ...

Apr 18, 2024
The Promising Fixed-duration Oral Regimen for Older and Unfit Patients with Chronic Lymphocytic Leukaemia

Chronic lymphocytic leukaemia (CLL) is a chronic lymphoproliferative disorder characterised by proliferation of monoclonal mature B-cells in peripheral blood, bone marrow, and secondary lymphoid tissues, such as spleen and lymph nodes 1 . The incide...

Jun 13, 2023
Proven Benefits of IMiDs-based Regimen in Managing Multiple Myeloma

Currently Available Therapeutic Options for MM MM is currently one of the most prevalent haematological malignancies, which mainly affects individuals aged above 65 2 , a relatively vulnerable group of patients owing to comorbidities and immunosenes...

Dec 20, 2021
Therapeutic Sequencing Strategy in Multiple Myeloma

The Multitude of Activities of IMiDs Because of the established benefits, IMiDs are recommended as induction therapy for both transplant eligible and ineligible patients, in the post-transplant maintenance setting, and for relapsed/refractory diseas...

Dec 20, 2021
Unmet Needs in Relapsed and Refractory Multiple Myeloma

Reduced Overall Survival in Refractory MM Although the application of the first IMiD, lenalidomide, had significantly increased median overall survival (OS) 2 , Prof. Leleu commented that the treatment success was hindered by the refractoriness of M...

Sep 20, 2021
Achieving Sustained Survival Benefits in Non-small Cell Lung Cancer

Standard Treatment Regimens for NSCLC and the Potential Challenges “Treatment goals vary across NSCLC patients at different stages of the disease. For patients at early and intermediate stages of NSCLC, they are usually treated with curative i...

Jun 21, 2021
Treatment of Multiple Myeloma: The Role of Immunomodulatory Drugs

T he Importance of Achieving Deepest Possible Response and Continuous Therapy While improving long-term survival for patients with MM is desirable, clinical data suggested that complete response (CR) to treatment is associated with survival outcomes...

Jun 21, 2021
Survival and Health-related Quality of Life in Prostate Cancer: What do We Expect in Darolutamide?

Uncovering Psychological Burden of Advanced Prostate Cancer Psychological distress is prevalent among patients with advanced PCa as compared to those with localised disease, and the morbidity adversely affects patients’ HRQOL 4 . Essentially, ...

Jun 21, 2021
Evidence of Effectiveness for Unresectable Locally Advanced Non-small Cell Lung Cancer

Poor Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) NSCLC, which accounts for 80-85% of all cases of lung cancer, constitute one of the leading causes of mortality worldwide 6,7 . In approximately 30% of patients, the diseas...

Mar 16, 2021
Preventing Faulty Alarm - Enhanced Diagnostic Accuracy with Gadoxetic Acid-enhanced MRI

Diagnostic Imaging for HCC in Local Clinical Practice Currently, local guideline on diagnostic imaging for HCC is yet to be developed, whereas various international diagnostic guidelines such as the Asian Pacific Association for the Study of the Liv...

Dec 15, 2020